Glenview Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09M | Buy |
3,978
+463
| +13% | +$243K | 0.04% | 214 |
|
|
2025
Q1 | $2.23M | Buy |
3,515
+444
| +14% | +$282K | 0.04% | 203 |
|
|
2024
Q4 | $2.19M | Buy |
3,071
+25
| +0.8% | +$17.8K | 0.04% | 198 |
|
|
2024
Q3 | $3.2M | Hold |
3,046
| – | – | 0.06% | 171 |
|
|
2024
Q2 | $3.2M | Sell |
3,046
-3
| -0.1% | -$3.15K | 0.06% | 164 |
|
|
2024
Q1 | $2.93M | Hold |
3,049
| – | – | 0.06% | 169 |
|
|
2023
Q4 | $2.68M | Sell |
3,049
-38
| -1% | -$33.4K | 0.07% | 171 |
|
|
2023
Q3 | $2.54M | Buy |
3,087
+29
| +0.9% | +$23.9K | 0.07% | 157 |
|
|
2023
Q2 | $2.2M | Sell |
3,058
-31
| -1% | -$22.3K | 0.06% | 171 |
|
|
2023
Q1 | $2.54M | Hold |
3,089
| – | – | 0.08% | 158 |
|
|
2022
Q4 | $2.23M | Buy |
3,089
+205
| +7% | +$148K | 0.07% | 158 |
|
|
2022
Q3 | $1.99M | Buy |
2,884
+333
| +13% | +$229K | 0.08% | 151 |
|
|
2022
Q2 | $1.51M | Buy |
2,551
+23
| +0.9% | +$13.6K | 0.06% | 167 |
|
|
2022
Q1 | $1.77M | Sell |
2,528
-1
| -0% | -$699 | 0.06% | 164 |
|
|
2021
Q4 | $1.6M | Sell |
2,529
-105
| -4% | -$66.3K | 0.05% | 170 |
|
|
2021
Q3 | $1.59M | Buy |
2,634
+25
| +1% | +$15.1K | 0.06% | 162 |
|
|
2021
Q2 | $1.46M | Buy |
2,609
+150
| +6% | +$83.8K | 0.06% | 168 |
|
|
2021
Q1 | $1.16M | Sell |
2,459
-24
| -1% | -$11.4K | 0.05% | 178 |
|
|
2020
Q4 | $1.2M | Sell |
2,483
-12
| -0.5% | -$5.8K | 0.06% | 167 |
|
|
2020
Q3 | $1.4M | Sell |
2,495
-775
| -24% | -$434K | 0.07% | 152 |
|
|
2020
Q2 | $2.04M | Buy |
3,270
+10
| +0.3% | +$6.24K | 0.12% | 123 |
|
|
2020
Q1 | $1.59M | Buy |
3,260
+45
| +1% | +$22K | 0.11% | 131 |
|
|
2019
Q4 | $1.21M | Buy |
3,215
+820
| +34% | +$308K | 0.07% | 167 |
|
|
2019
Q3 | $664K | Buy |
2,395
+1,165
| +95% | +$323K | 0.04% | 212 |
|
|
2019
Q2 | $385K | Buy |
+1,230
| New | +$385K | 0.02% | 258 |
|